Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegasys Post-marketing Study in Chronic Hepatitis C
NCT00245414Phase 4Completed
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Oct 2005
- Primary completion
- Jul 2010
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of interferon alfa in hepatitis C (HCV) (4 arms), sponsored by Chugai Pharmaceutical Co., Ltd. Primary endpoint: Sustained Viral Response. Started Oct 2005; status: completed.
02
Drugs
interferon alfa
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00245414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00245414.